https://www.selleckchem.com/pr....oducts/Gefitinib.htm
phenomenon. Its clinical symptoms, imaging, and pathological manifestations need to be distinguished from other bone lesions. The molecular detection of BRAF V600E and the nuclear expression of cyclin D1 mutations can be used for the diagnosis and differential diagnosis of RDD.Objective To investigate the expression of microRNA-140-5p (miR-140-5p) in esophageal squamous cell carcinoma (ESCC) and its role in cell proliferation and invasion of ESCC. Methods Real-time quantitative PCR (qPCR) was used to detect the expression levels of mi
Respect!
Kommentar
Delen
